CRISPR

Companies Produce First Genetically Engineered Porcine Donors

February 16, 2024 - On February 13, 2024, eGenesis, a United States-based biotechnology company, and PorMedTec, a Japanese porcine embryology organization, announced positive results of their collaboration, which produced the first successful genetically engineered porcine donors for xenotransplantation. “Production of our first donors outside the United States...


More Articles

CRISPR Treatment in Clinical Trial for Pediatric Sickle Cell Disease

by Veronica Salib

The European Hematology Association (EHA) recently released results from a clinical trial that implied the potential benefits of using CRISPR treatment to address pediatric sickle cell disease (SCD)....